Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.87 USD
Change Today +0.03 / 1.06%
Volume 50.3K
ENZ On Other Exchanges
Symbol
Exchange
New York
Munich
As of 8:04 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Dean Engelhardt Ph.D.

Executive Vice President,Enzo Biochem Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

75--

Background*

Dean Engelhardt, Ph.D. has been Executive Vice President of Enzo Biochem Inc. since July 2000. Dr. Engelhardt served as Senior Vice President of Enzo Biochem Inc. from January 1989 to June 2000 and its Vice President from September 1981 to December 1988. Prior to joining Enzo Biochem Inc., he served as an Associate Professor of Microbiology at Columbia University College of Physicians and Surgeons. Dr. Engelhardt obtained his Ph.D. in Molecular Genetics from Rockefeller ...

Read Full Background

Corporate Headquarters*

527 Madison Avenue
New York, New York 10022

United States

Phone: 212-583-0100
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
Rockefeller University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ENZ:US $2.87 USD +0.03

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
William J. Welch M.B.A.Chief Executive Officer, President and Director
Sequenom Inc.
$433.0K
Raymond C. Kubacki Jr.Chairman, Chief Executive Officer and President
Psychemedics Corp.
$536.9K
Douglas M. VanOort Executive Chairman and Chief Executive Officer
Neogenomics Inc.
$735.3K
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Michael W. Hunkapiller Ph.D.Executive Chairman, Chief Executive Officer and President
Pacific Biosciences of California, Inc.
$1.00
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ENZO BIOCHEM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.